Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms-Reference-Cited by-同舟云学术

Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

Published:2015-04-30 Issue:17 Volume:21 Page:2291-2303
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Harsing Jr. Laszlo G.¹,Timar Julia¹,Szabo Geza¹,Udvari Szabolcs¹,Nagy Katalin M.¹,Marko Bernadett¹,Zsilla Gabriella¹,Czompa Andrea¹,Tapolcsanyi Pal¹,Kocsis Akos¹,Matyus Peter¹

Affiliation:

1. Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Nagyvarad ter 4, Hungary.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diastereoselective synthesis of functionalized tetrahydropyridazines containing indole scaffolds via an inverse-electron-demand aza-Diels–Alder reaction;Organic Chemistry Frontiers;2021

2. The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model;BMC Psychiatry;2019-10-25

3. Glycine transporter inhibitors: A new avenue for managing neuropathic pain;Brain Research Bulletin;2019-10

4. Modulating NMDA Receptor Function with d-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model;Neurochemical Research;2016-02

5. Synthesis of functionalized tetrahydropyridazines via catalyst-free self [4 + 2] cycloaddition of in situ generated 1,2-diaza-1,3-dienes;RSC Advances;2016